Pfizer, the first pharmaceutical company to develop the first authorized COVID-19 vaccine in the United States, will begin to calculate the additional dose of the vaccine found in vials by pharmacists at the end of last year to fulfill its contractual obligations with the US government.
according to New York TimesThis move was made possible because the US Food and Drug Administration (FDA) changed the term in the authorization-to allow the public to use the COVID-19 vaccine-to indicate that six doses can be extracted from the vial.
Although each medicine bottle can only hold five doses of the COVID-1
In order to extract the extra dose from the vial, the pharmacist will need to use a low dead-angle syringe, which will maximize the number of vaccines that can be used in each vial.However, as a political notesHowever, pharmacists are not always able to use these syringes.
The Washington Post quoted an anonymous official as saying that the negotiations ended, report The sixth dose is calculated only when shipped with the low dead space syringe. Since then, the “New York Times” reported the same thing.
From the “Washington Post”:
An unnamed negotiator revealed that the Biden administration and Pfizer signed an agreement last Friday that will allow the government to track which goods are accompanied by low dead-angle syringes and which do not.
Pfizer’s 200 million needles contract stipulates that the vial with an ordinary syringe will be counted as five doses, and the vial accompanying a special syringe will be counted as six needles for the contract.
The New York Times first reported the language change in emergency use authorization. The report reported that special syringes that can extract additional doses can be used in more than 70% of vaccination sites.
From New York Times:
In late December, federal health officials tried to find out whether there were enough dedicated syringes to justify the transition. A person familiar with the matter said that CDC officials said they were not sure whether the supply was sufficient.
However, according to another person familiar with the matter, the federal health official responsible for managing government syringe contracts told the FDA that more than 70% of sites are using more efficient syringes and can easily buy or manufacture more syringes.
Pfizer spokesperson Amy Rose (Amy Rose) said in a statement to Politico on Friday: “We will fulfill our supply commitments in accordance with existing agreements, which are based on dosage rather than delivery of vials.” According to a report in the Washington Post, the Biden administration plans to increase the availability of syringes needed to extract the sixth dose. It is not clear how long it will take.
The Daily Telegraph is one of the fastest-growing conservative media companies in the United States and a counter-cultural media for news, opinions, and entertainment.Become an internal visitor to the Daily Telegraph member.